817 related articles for article (PubMed ID: 19843643)
21.
Anwar SL; Krech T; Hasemeier B; Schipper E; Schweitzer N; Vogel A; Kreipe H; Buurman R; Skawran B; Lehmann U
World J Gastroenterol; 2017 Mar; 23(9):1568-1575. PubMed ID: 28321157
[TBL] [Abstract][Full Text] [Related]
22. Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma.
Gramantieri L; Ferracin M; Fornari F; Veronese A; Sabbioni S; Liu CG; Calin GA; Giovannini C; Ferrazzi E; Grazi GL; Croce CM; Bolondi L; Negrini M
Cancer Res; 2007 Jul; 67(13):6092-9. PubMed ID: 17616664
[TBL] [Abstract][Full Text] [Related]
23. [The relationship between microRNA-18 and BTG2 in the carcinogenesis of hepatocellular carcinoma].
Li Q; Wang G; Zhang ZM
Zhonghua Gan Zang Bing Za Zhi; 2009 Jan; 17(1):42-5. PubMed ID: 19203451
[TBL] [Abstract][Full Text] [Related]
24. Methyl-CpG binding protein MBD2 is implicated in methylation-mediated suppression of miR-373 in hilar cholangiocarcinoma.
Chen Y; Gao W; Luo J; Tian R; Sun H; Zou S
Oncol Rep; 2011 Feb; 25(2):443-51. PubMed ID: 21165562
[TBL] [Abstract][Full Text] [Related]
25. Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues.
Murakami Y; Yasuda T; Saigo K; Urashima T; Toyoda H; Okanoue T; Shimotohno K
Oncogene; 2006 Apr; 25(17):2537-45. PubMed ID: 16331254
[TBL] [Abstract][Full Text] [Related]
26. Frequent epigenetic silencing of the CpG island promoter of RASSF1A in thyroid carcinoma.
Schagdarsurengin U; Gimm O; Hoang-Vu C; Dralle H; Pfeifer GP; Dammann R
Cancer Res; 2002 Jul; 62(13):3698-701. PubMed ID: 12097277
[TBL] [Abstract][Full Text] [Related]
27. Methylome analysis and integrative profiling of human HCCs identify novel protumorigenic factors.
Neumann O; Kesselmeier M; Geffers R; Pellegrino R; Radlwimmer B; Hoffmann K; Ehemann V; Schemmer P; Schirmacher P; Lorenzo Bermejo J; Longerich T
Hepatology; 2012 Nov; 56(5):1817-27. PubMed ID: 22689435
[TBL] [Abstract][Full Text] [Related]
28. Frequent methylation-associated silencing of a candidate tumor-suppressor, CRABP1, in esophageal squamous-cell carcinoma.
Tanaka K; Imoto I; Inoue J; Kozaki K; Tsuda H; Shimada Y; Aiko S; Yoshizumi Y; Iwai T; Kawano T; Inazawa J
Oncogene; 2007 Sep; 26(44):6456-68. PubMed ID: 17438526
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA-500 as a potential diagnostic marker for hepatocellular carcinoma.
Yamamoto Y; Kosaka N; Tanaka M; Koizumi F; Kanai Y; Mizutani T; Murakami Y; Kuroda M; Miyajima A; Kato T; Ochiya T
Biomarkers; 2009 Nov; 14(7):529-38. PubMed ID: 19863192
[TBL] [Abstract][Full Text] [Related]
30. Down-regulated microRNA-152 induces aberrant DNA methylation in hepatitis B virus-related hepatocellular carcinoma by targeting DNA methyltransferase 1.
Huang J; Wang Y; Guo Y; Sun S
Hepatology; 2010 Jul; 52(1):60-70. PubMed ID: 20578129
[TBL] [Abstract][Full Text] [Related]
31. [Correlations of CpG island methylator phenotype and OPCML gene methylation to carcinogenesis of hepatocellular carcinoma].
Liu WJ; Wang L; Wang JP; Li JQ; Zhang CQ; Zheng L; Yuan YF
Ai Zheng; 2006 Jun; 25(6):696-700. PubMed ID: 16764763
[TBL] [Abstract][Full Text] [Related]
32. Potential of tumor-suppressive miR-596 targeting LGALS3BP as a therapeutic agent in oral cancer.
Endo H; Muramatsu T; Furuta M; Uzawa N; Pimkhaokham A; Amagasa T; Inazawa J; Kozaki K
Carcinogenesis; 2013 Mar; 34(3):560-9. PubMed ID: 23233740
[TBL] [Abstract][Full Text] [Related]
33. Aberrant DNA methylation profile and frequent methylation of KLK10 and OXGR1 genes in hepatocellular carcinoma.
Lu CY; Hsieh SY; Lu YJ; Wu CS; Chen LC; Lo SJ; Wu CT; Chou MY; Huang TH; Chang YS
Genes Chromosomes Cancer; 2009 Dec; 48(12):1057-68. PubMed ID: 19760608
[TBL] [Abstract][Full Text] [Related]
34. Hepatocyte growth factor activator inhibitor 2/placental bikunin (HAI-2/PB) gene is frequently hypermethylated in human hepatocellular carcinoma.
Fukai K; Yokosuka O; Chiba T; Hirasawa Y; Tada M; Imazeki F; Kataoka H; Saisho H
Cancer Res; 2003 Dec; 63(24):8674-9. PubMed ID: 14695180
[TBL] [Abstract][Full Text] [Related]
35. NORE1B, a candidate tumor suppressor, is epigenetically silenced in human hepatocellular carcinoma.
Macheiner D; Heller G; Kappel S; Bichler C; Stättner S; Ziegler B; Kandioler D; Wrba F; Schulte-Hermann R; Zöchbauer-Müller S; Grasl-Kraupp B
J Hepatol; 2006 Jul; 45(1):81-9. PubMed ID: 16516329
[TBL] [Abstract][Full Text] [Related]
36. The tumor suppressive microRNA miR-218 targets the mTOR component Rictor and inhibits AKT phosphorylation in oral cancer.
Uesugi A; Kozaki K; Tsuruta T; Furuta M; Morita K; Imoto I; Omura K; Inazawa J
Cancer Res; 2011 Sep; 71(17):5765-78. PubMed ID: 21795477
[TBL] [Abstract][Full Text] [Related]
37. Epigenetic regulation of microRNAs in acute lymphoblastic leukemia.
Roman-Gomez J; Agirre X; Jiménez-Velasco A; Arqueros V; Vilas-Zornoza A; Rodriguez-Otero P; Martin-Subero I; Garate L; Cordeu L; San José-Eneriz E; Martin V; Castillejo JA; Bandrés E; Calasanz MJ; Siebert R; Heiniger A; Torres A; Prosper F
J Clin Oncol; 2009 Mar; 27(8):1316-22. PubMed ID: 19164206
[TBL] [Abstract][Full Text] [Related]
38. Methylation of a panel of microRNA genes is a novel biomarker for detection of bladder cancer.
Shimizu T; Suzuki H; Nojima M; Kitamura H; Yamamoto E; Maruyama R; Ashida M; Hatahira T; Kai M; Masumori N; Tokino T; Imai K; Tsukamoto T; Toyota M
Eur Urol; 2013 Jun; 63(6):1091-100. PubMed ID: 23200812
[TBL] [Abstract][Full Text] [Related]
39. The assessment of methylated BASP1 and SRD5A2 levels in the detection of early hepatocellular carcinoma.
Tsunedomi R; Ogawa Y; Iizuka N; Sakamoto K; Tamesa T; Moribe T; Oka M
Int J Oncol; 2010 Jan; 36(1):205-12. PubMed ID: 19956849
[TBL] [Abstract][Full Text] [Related]
40. Genetic characterization of fas-associated phosphatase-1 as a putative tumor suppressor gene on chromosome 4q21.3 in hepatocellular carcinoma.
Yeh SH; Wu DC; Tsai CY; Kuo TJ; Yu WC; Chang YS; Chen CL; Chang CF; Chen DS; Chen PJ
Clin Cancer Res; 2006 Feb; 12(4):1097-108. PubMed ID: 16489062
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
